Boston Therapeutics to Exhibit at 2013 American Association

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Boston Therapeutics to Exhibit at 2013 American Association of Diabetes Educators Annual Meeting & Exhibition in Philadelphia

MANCHESTER, NH--(Marketwired - Aug 2, 2013) - Boston Therapeutics, Inc. ( OTCQB : BTHE ) ("Boston Therapeutics" or "the Company"), a pharmaceutical company developing and commercializing complex carbohydrate-based drugs to treat diabetes and inflammatory diseases, will exhibit at the 2013 American Association of Diabetes Educators Annual Meeting & Exhibition (AADE13) in Philadelphia from August 7-9.

Kenneth Tassey, Jr., President, and David Platt, Ph.D., CEO, will be in attendance.

The Company will feature the positive results from its Phase II clinical trial evaluating the safety and efficacy of PAZ320, in which 45 percent of patients responded with a 40 percent reduction of post-meal glucose in the blood compared to baseline in a dose-dependent manner. PAZ320 is a complex carbohydrate-based drug candidate designed to reduce the elevation of post-meal blood glucose by blocking the action of carbohydrate-hydrolyzing enzymes. There were no serious adverse events in the Phase II trial conducted at Dartmouth Medical Center in NH.

The AADE13 Annual Meeting & Exhibition is the only large-scale professional event focused solely on diabetes education. AADE13 attendees learn how to improve patient outcomes, teach diverse populations, maximize reimbursement, market diabetes education services and broaden the reach of diabetes education into different practice settings. AADE13 provides strong personal and professional benefits, providing state-of-the-art clinical updates, an exhibit hall full of the latest technologies and treatments, research from thought leaders in the field and unparalleled networking opportunities.

About Boston Therapeutics, Inc.

Boston Therapeutics, headquartered in Manchester, NH, ( OTCQB : BTHE ) is a leader in the field of complex carbohydrate chemistry. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including PAZ320, a non-systemic chewable therapeutic compound designed to reduce the elevation of post-prandial glucose (PPG) or post-meal blood sugar, and IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia associated with diabetes. More information is available at www.bostonti.com .

Forward Looking Statements

Any statements in this news release about future expectations, plans and prospects for the Company constitute forward-looking statements as defined in the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in such statements.

More information about those risks and uncertainties is contained and discussed in the Company's most recent quarterly or annual report and in the Company's other reports filed with the Securities and Exchange Commission. The forward-looking statements represent the Company's views as of the date of this news release and should not be relied upon to represent the Company's views as of a subsequent date. While the Company anticipates that subsequent events may cause the Company's views to change, the Company disclaims any obligation to update such forward-looking statements.

Contact: Boston Therapeutics, Inc. Anthony Squeglia Director of Strategic Planning Phone: 603-935-9799 Email: anthony.squeglia@bostonti.com www.bostonti.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYY’s Ad Engine Gives Q3 Growth Some Real Teeth Now

Updated Category News Views 107

Three engines are finally pulling the cart at JOYY, and that is a far more interesting sight than another quarter of livestreaming merely holding together. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% sequentially. Those are sturdy numbers, especially for a business that investors have long tended to box in as...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 122

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 153

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
Liquidity Services Faces a Brutal Revenue Reality Check

Updated Category News Views 0

A 19.17% opening haircut is the market ringing the fire alarm, not politely clearing its throat. Liquidity Services reported fiscal fourth-quarter revenue of $106.4 million, roughly 10% below the prior-year quarter, and shareholders got hit hard on November 19, 2026. That reaction is ugly, but it is not mysterious. When a company built around moving surplus inventory...

Continue Reading
Nvidia Lawsuit Allegations Put Disclosure Risk in Focus

Updated Category News Views 67

A lawsuit notice can turn a roaring chip story sour in a hurry, and this one deserves a cold, careful read rather than the usual internet stampede. DJS Law Group says it has filed a securities class action against NVIDIA, alleging that the company made materially false and misleading statements during a stated class period running from October 9, 2025 through November 8,...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 61

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 134

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
Satellite NTN's $3.22B Promise Needs Real Receipts

Updated Category News Views 64

Dead zones over oceans, deserts, and flight paths are finally becoming a serious commercial problem, not merely a neat engineering demo. That is the muscle behind the satellite non-terrestrial network, or NTN, pitch: connect aircraft, vessels, remote assets, and scattered sensors where terrestrial networks simply do not reach. MarketsandMarkets projects this market will...

Continue Reading

Top 5 Most Recently Viewed Articles

Stantec Gears Up for Q2 2025 Results and Insights Call

Updated Category News Views 119

Stantec Prepares for Q2 2025 Financial Results EDMONTON, Alberta — Stantec, recognized globally for its commitment to sustainable design and engineering, is gearing up to release its second quarter 2025 financial results shortly after market closure on a Wednesday in mid-August. The company’s steadfast dedication to enhancing communities through innovation and...

Continue Reading
Hyundai Motor's INITIUM: A Step Towards Hydrogen Mobility

Updated Category News Views 168

Hyundai Motor Explores a Hydrogen Future with INITIUM Concept Hyundai Motor Company recently held an inspiring event named 'Clearly Committed,' demonstrating its dedication to a future powered by hydrogen fuel technology. During this event, the company unveiled its latest hydrogen fuel cell electric vehicle (FCEV) concept, the INITIUM. The Meaning Behind INITIUM The term...

Continue Reading
Target Hospitality Enhances Community Capacity to Meet Demand

Updated Category News Views 130

Target Hospitality Expands Modular Accommodations Target Hospitality Corp. (NASDAQ: TH), a leading provider in the hospitality sector, recently announced a significant expansion of its modular accommodation community. This upgrade represents a 160% increase from their initial offering, aimed at meeting the surging demands of clients in the growing data center industry....

Continue Reading
Nutex Health's Legal Challenge: Misclaimed Bills & Investor Impact

Updated Category News Views 193

Nutex Health Faces Serious Legal Scrutiny Nutex Health Inc. (NASDAQ: NUTX), a company that operates micro-hospitals and healthcare facilities, finds itself in a challenging position as it deals with a class-action lawsuit. This litigation accuses the company of engaging in deceptive billing practices intended to inflate its financial performance. The lawsuit, filed in a...

Continue Reading
Exciting Developments in Uranium Exploration at Foremost Clean Energy

Updated Category News Views 194

Significant Findings at Hatchet Lake Project Foremost Clean Energy Ltd. (NASDAQ: FMST) has announced intriguing results from its latest drilling program at the Hatchet Lake Uranium Property, marking a significant milestone in its exploration efforts. These results stem from their rigorous winter drill program, which underscored the property’s potential for uranium...

Continue Reading